- Home
- SOBR vs ONCO Comparison
SOBR vs ONCO Comparison
Compare SOBR & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOBR
- ONCO
- Stock Information
- Founded
- SOBR 2004
- ONCO 2018
- Country
- SOBR United States
- ONCO United States
- Employees
- SOBR N/A
- ONCO N/A
- Industry
- SOBR Newspapers/Magazines
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- SOBR Consumer Discretionary
- ONCO Health Care
- Exchange
- SOBR Nasdaq
- ONCO Nasdaq
- Market Cap
- SOBR 5.2M
- ONCO 4.7M
- IPO Year
- SOBR N/A
- ONCO 2022
- Fundamental
- Price
- SOBR N/A
- ONCO $3.82
- Analyst Decision
- SOBR
- ONCO
- Analyst Count
- SOBR 0
- ONCO 0
- Target Price
- SOBR N/A
- ONCO N/A
- AVG Volume (30 Days)
- SOBR 14.9K
- ONCO 266.4K
- Earning Date
- SOBR 11-13-2025
- ONCO 08-14-2025
- Dividend Yield
- SOBR N/A
- ONCO N/A
- EPS Growth
- SOBR N/A
- ONCO N/A
- EPS
- SOBR N/A
- ONCO N/A
- Revenue
- SOBR $301,400.00
- ONCO $1,326,959.00
- Revenue This Year
- SOBR N/A
- ONCO N/A
- Revenue Next Year
- SOBR N/A
- ONCO N/A
- P/E Ratio
- SOBR N/A
- ONCO N/A
- Revenue Growth
- SOBR 73.21
- ONCO N/A
- 52 Week Low
- SOBR $2.41
- ONCO $2.45
- 52 Week High
- SOBR $193.50
- ONCO $552.50
- Technical
- Relative Strength Index (RSI)
- SOBR 43.87
- ONCO 60.58
- Support Level
- SOBR $3.18
- ONCO $3.02
- Resistance Level
- SOBR $3.35
- ONCO $3.24
- Average True Range (ATR)
- SOBR 0.12
- ONCO 0.32
- MACD
- SOBR -0.00
- ONCO 0.04
- Stochastic Oscillator
- SOBR 20.51
- ONCO 80.46
About SOBR SOBR Safe Inc.
Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.